Venus Remedies surges; to collaborate with Teva on drug

Reuters Market Eye - Venus Remedies Ltd shares surge as much as 14.9 percent.

Venus will collaborate with Teva Pharmaceutical Industries Ltd to develop an anti-cancer drug, it said in a statement on Tuesday. (http://bit.ly/1tBRHtj)

The company did not provide financial details of the deal.

(Reporting by Dipika Lalwani)